Chengkui Yang

发表

Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

T. Yang, Sheng Tian, Jingrui Wang, 2021, European journal of medicinal chemistry.

Correction: Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion

J. Xu, S. Mitani, Chonglin Yang, 2016, The Journal of cell biology.

Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion

S. Mitani, Chonglin Yang, Xiaojuan Sun, 2016, The Journal of cell biology.

Interferon‐mediated repression of miR‐324‐5p potentiates necroptosis to facilitate antiviral defense

H. Zhang, Wei Zhang, Xiaoliang Yu, 2022, EMBO reports.

Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis through the Viral Ribonucleotide Reductase Large Subunit R1

Qin Chen, C. Zheng, Chenhe Su, 2015, Journal of Virology.

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury

Jingrui Wang, Xiaohu Zhang, Haikuo Ma, 2020, Frontiers in Cell and Developmental Biology.

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Feng Ma, Sheng Tian, Xiaohu Zhang, 2022, Blood.

Aqueous synthesized quantum dots interfere with the NF-κB pathway and confer anti-tumor, anti-viral and anti-inflammatory effects.

Lei Xu, X. Ji, Yuanyuan Su, 2016, Biomaterials.

Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis

Xiu-xia Zhou, Lang Jiang, S. He, 2017, Cell Death and Disease.

Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2022, Bioorganic chemistry.

Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis

Cong Zhao, Yifei Zhou, Qiao Ran, 2020, Apoptosis.

Endothelial Overexpression of Metallothionein Prevents Diabetes-Induced Impairment in Ischemia Angiogenesis Through Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

F. Shen, Jianxiang Xu, Z. Deng, 2020, Diabetes.

Endothelial overexpression of metallothionein prevents diabetes mellitus-induced impairment in ischemia angiogenesis via preservation of HIF-1α/SDF-1/VEGF signaling in endothelial progenitor cells

F. Shen, Jianxiang Xu, Z. Deng, 2020 .

Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease.

Xin Chen, Xiaohu Zhang, Xue-bo Sun, 2023, Biochemical pharmacology.